Post by prosper on Sept 5, 2016 12:24:03 GMT -5
Pharmacist friend and fellow stockholder sent me this
www.medscape.com/viewarticle/867404#vp_2
www.medscape.com/viewarticle/835395_2
clinicaltrials.gov/ct2/show/NCT02870361?term=nasal+insulin&rank=11
This research is very preliminary, but I believe that there is some validity. I believe that you will see inhaled insulin being used for patients with both diabetes and dementia because the inhaled insulin seems to cross the blood-brain barrier. Diabetes patients are something in the range of 3 times more likely to get Alzheimers than someone without diabetes. You might want to check with the Afrezza company to see what they are doing